The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Downgrades Rolls-Royce To Sell

Mon, 16th Jun 2014 09:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BARCLAYS RAISES RSA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 538 (102) PENCE
----------
SOCGEN CUTS ROLLS-ROYCE TO 'SELL' ('HOLD') - TARGET 950 (1070) PENCE
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 2100 (2075) PENCE - 'BUY'
----------
HSBC RAISES BG GROUP PRICE TARGET TO 1425 (1260) PENCE - 'OVERWEIGHT'
----------
EXANE RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4500) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS BHP BILLITON PRICE TARGET TO 1850 (2000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS RIO TINTO PRICE TARGET TO 3800 (4070) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES WEIR GROUP PRICE TARGET TO 2540 (2390) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
GOLDMAN RAISES HISCOX PRICE TARGET TO 607 (606,74) PENCE - 'SELL'
----------
HSBC RAISES PARAGON GROUP PRICE TARGET TO 380 (335) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES DEBENHAMS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TP 73 (64) PENCE
----------
CREDIT SUISSE CUTS FENNER PRICE TARGET TO 405 (490) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES HALMA PRICE TARGET TO 665 (620) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES LAIRD PRICE TARGET TO 270 (215) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE RAISES MORGAN ADVANCED MATERIALS TP TO 310 (270) PENCE - 'UNDERPEFORM'
----------
CREDIT SUISSE RAISES ROTORK PRICE TARGET TO 2600 (2450) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SENIOR PLC PRICE TARGET TO 335 (315) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
NUMIS CUTS CRODA PRICE TARGET TO 2554 (2575) PENCE - 'HOLD'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 119 (122) PENCE - 'NEUTRAL'
----------
LIBERUM INITIATES NCC GROUP WITH 'BUY' - TARGET 220 PENCE
----------
Investec Cuts Majestic Wine To Add from Buy, PT 460p
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.